βββββInformal Comment Period for Certain Regulations
The informal comment period is open from
April 20 - May 20, 2026 for the following COMAR sections
10.34.15 Licensure by Reciprocity
10.34.32 Pharmacist Administration of Vaccinationsβ
Please email your comments to:
Deena Speights-Napata, MA.
Executive Director
Maryland Board of Pharmacy
deena.speights-napata@maryland.gov
The comments will be reviewed by the board and considered for incorporation in the regulation if appropriate.
The format comment period will begin when the regulations are sent to the Department of Regulations Office of Policy Coordination and accepted for posting in the Maryland Register.
Comments can be submitted during both the informal and formal processes.
Should you have any questions or concerns, please contact:
Deena Speights-Napata, M.A.
Executive Director
Maryland Board of Pharmacy
deena.speights-napata@maryland.gov
β
Pharmacy Jurisprudence Exam Update
Beginning on June 1, 2026, the Maryland Board of Pharmacy will allow pharmacist licensure applicants to choose whether to take either the Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE) or the state MPJE as part of licensure requirements.
If the UMPJE is selected, pharmacistβ licensure applicants will also be required to take a Maryland-specific module similar in design to a CE program consisting of recorded materials and a competency assessment.
Details on the Maryland module will be provided within the next 30 days. Please check the board's website for additional details.
________________________________β
Pharmacy News & Views
Please Click Here
________________________________________β
Hepatitis B Vaccine Standing Order
βPlease Click Hereβ
________________________________________
Governor Moore Launches Free Adult Vaccine Program to Expand Immunization Access for Uninsured and Underinsured Marylandersβ
Please click hereβ
______________________________________________________
Updated MDH Healthcare Provβider Respiratory Illness Return to Work Guidance
Please see the attached clinician letter from the Maryland Department of Health providing updated respiratory illness-related healtcare provider return to work guidance.
Please click hereβ
β